10th Annual Pharma Pricing, Reimbursement & Market Access 2026

10th Annual Pharma Pricing, Reimbursement & Market Access 2026 is organized by Virtue Insight and will be held from Sep 02 - 03, 2026 at Live! Casino & Hotel Philadelphia, Philadelphia, Pennsylvania, United States of America.

Description:
Pharma Pricing, Reimbursement & Market Access Conference brings together global stakeholders - including industry leaders, payers, HTA bodies, regulators, physicians, and patient advocates—to explore the latest challenges, opportunities, and innovations shaping access to medicines. Through thought-provoking panels, case studies, and interactive discussions, this event will address key themes such as value-based access models, regulatory developments, real-world evidence integration, digital health, global pricing strategies, and the growing importance of patient and payer collaboration.

Event Highlights:

• Expert Speaker Line-up
• Insightful Presentations
• Interactive Panel Discussions
• Exclusive Round Table Sessions
• Networking Opportunities

Key Speakers:

• RODNEY EMERSON, Vice President, Pricing & Contracts, Sandoz
• TOM CROCE, VP, Global Patient Advocacy & Engagement, Jazz Pharmaceuticals
• SHANTHY KRISHNARAJAH, Sr. Director, New Products, Patient Engagement Research Council & IRA, Johnson & Johnson
• JOAQUIN MOULD, Global HEOR & Value Strategy Director, CSL Seqirus
• DIEGO CORTINA DE LA FUENTE, Global Value & Access Oncology Lead Solid Tumors, Takeda
• NADIA TANTSYURA, Executive Director, Commercial AI & Advanced Analytics, Bristol Myers Squibb
• JEETVAN PATEL, Sr. Director, Franchise Head US HEOR -,Radioligand Therapies, Novartis
• JAMIE GROSSMAN, National Account Director, HEOR, Bayer
• RYAN COELHO, Net Revenue Management (Strategic Pricing) Director, Zoetis
• MELISSA HAGAN, Director, Strategic Evidence Market Access, BeOne Medicines
• ADAM KUNDZEWICZ, Head of Market Access & Healthcare Affairs, Boehringer Ingelheim
• OMAR ALI, Head of Payers, Verpora
• JIE ZHANG, Head, Global Pipeline Market Access, CSL
• ROSALIND DAVIS, Head of Government Pricing & Market Access Operations CSL Vifor
• BOXIONG TANG, Head of Global Health Economics & Outcomes Research (GHEOR), Ascentage Pharma
• ROBERT KEMP, VP of Market Access & HEOR, Digital Therapeutics, Government Affairs, Breath Therapeutics
• DINAKARAN BALASUBRAMANIAN, Head, Commercial Strategy & Insights Biologics, Dr. Reddy’s Laboratories
• ANKA EHRHARDT, Director, Cell-Based Assays, Analytical Research & Development, Merck
• RAHUL SHENOLIKAR, Head, Center for Oncology Data Excellence, AstraZeneca
• YAOZHU (JULIETTE) CHEN, Evidence Strategist, Patient-Centric, Developer, Value Solution Leade, Astrazeneca
• HEATHER LEIGH FLANNERY, CEO & Co-Founder, AI MINDSystems Foundation
• STEPHEN FRAMIL, CEO, Ai1Y (Former Corporate Global, Head of Accessibility, Merck)   
• CHERYL ROCHE ALEXANDER, Former Account Experience Specialist, UCB
• AYESHA AZAM, Senior Director, Client Partnerships, Avalere Health
• PETER BARSCHDORFF, Vice President, Deallus
• ASHLEY JAKSA, Principal, Research Partnerships Target RWE